Dr Rick Strassman, currently an Adjunct Associate Professor of Psychiatry at the University of New Mexico, is one of the leading pioneers of modern psychedelic research. His studies on DMT, which took place between 1990 and 1995, broke the 20-year gap in psychedelic research. This halting of prolific and promising inquiry was because the US…
View Post
Psychedelics are known to enhance suggestibility – in other words, the quality of being inclined to accept and act on the suggestions of others. (Interestingly, those who score high in trait conscientiousness – or being careful, diligent, efficient, and organised – are the most sensitive to this effect of psychedelics.) Psychedelic users are well aware…
View Post
There are classic psychedelics (psilocybin, LSD, DMT) and non-classic psychedelics (ketamine, MDMA) that receive a lot of scientific and public attention regarding their potential mental health benefits. These are substances that, when combined with psychotherapy, can be helpful in resolving or alleviating conditions such as depressive and anxiety disorders, post-traumatic stress disorder (PTSD), and addiction.…
View Post
According to the Czech psychiatrist and LSD researcher Stan Grof, psychedelics are “nonspecific amplifiers” of the human psyche – they amplify whatever contents exist in the mind, be they conscious or unconscious. This description of these unique substances has since become a widely accepted way of thinking about them. But is it an accurate description?…
View Post
The feeling of gaining direct knowledge of something grand or important about reality is a common aspect of mystical experiences generally and psychedelic mystical states more specifically. This is known as a noetic experience, one of the four defining qualities of a mystical experience, as propounded by the American psychologist and philosopher William James in…
View Post